deferoxamine has been researched along with vanadates in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corbella, J; Domingo, JL; Gómez, M; Llobet, JM | 1 |
Darr, D; Fridovich, I | 1 |
Hamada, T | 1 |
Castranova, V; Ding, M; Leonard, SS; Millecchia, L; Robinson, VA; Shi, X; Vallyathan, V; Ye, J; Zhang, X | 1 |
Chen, GQ; Jiang, Y; Wang, LS; Xue, ZH; Yu, Y; Zhao, Q | 1 |
Chen, GQ; Guo, M; Jiang, Y; Liu, W; Song, LP; Yu, Y | 1 |
6 other study(ies) available for deferoxamine and vanadates
Article | Year |
---|---|
Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Administration, Oral; Animals; Ascorbic Acid; Chelating Agents; Deferoxamine; Male; Rats; Rats, Inbred Strains; Thiomalates; Tissue Distribution; Vanadates; Vanadium; Vanadium Compounds | 1991 |
Vanadate enhancement of the oxidation of NADH by O2-: effects of phosphate and chelating agents.
Topics: Animals; Cattle; Chelating Agents; Deferoxamine; NAD; NADP; Oxygen; Phosphates; Spectrophotometry; Time Factors; Tromethamine; Vanadates; Vanadium | 1985 |
Vanadium induced hemolysis of vitamin E deficient erythrocytes in Hepes buffer.
Topics: Analysis of Variance; Animals; Chelating Agents; Cricetinae; Deferoxamine; Erythrocytes; Free Radical Scavengers; Free Radicals; Hemolysis; HEPES; Hydroxyl Radical; Male; Mesocricetus; NADP; Phosphates; Tromethamine; Vanadates; Vanadium; Vitamin E Deficiency | 1994 |
Vanadate induces apoptosis in epidermal JB6 P+ cells via hydrogen peroxide-mediated reactions.
Topics: Animals; Apoptosis; Catalase; Cell Line; Cell Nucleus; Deferoxamine; Epidermis; Formates; Hydrogen Peroxide; Kinetics; Mice; NADP; Oxygen Consumption; Superoxide Dismutase; Vanadates | 1999 |
Metavanadate suppresses desferrioxamine-induced leukemic cell differentiation with reduced hypoxia-inducible factor-1alpha protein.
Topics: Animals; Blotting, Western; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; COS Cells; Deferoxamine; Granulocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia; Luciferases; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; U937 Cells; Vanadates | 2005 |
Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms.
Topics: Base Sequence; Caspase 3; Caspase 8; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; DNA Primers; Gene Dosage; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia; Membrane Potential, Mitochondrial; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Nitroprusside; Proto-Oncogene Proteins c-bcl-2; U937 Cells; Vanadates | 2006 |